NEW YORK (360Dx) – The US Food and Drug Administration has granted 510(k) clearance for a line of clinical chemistry and immunoassay diagnostic instruments from Abbott, the firm announced today.

The Alinity c clinical chemistry system and Alinity i immunoassay system can be used individually or as an integrated Alinity ci-series unit, Abbott noted in a statement, adding the ci-series instruments have half the footprint of existing systems due to its stacked design.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.